Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT)

53 filings reported holding BOLT - Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share as of Q4 2022.
Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 20.5M shares of 38.5M outstanding shares and own 53.26% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (3.87M shares), Sofinnova Investments, Inc. (2.75M shares), CITADEL ADVISORS LLC (2.75M shares), Pivotal bioVenture Partners Investment Advisor LLC (1.89M shares), Nan Fung Group Holdings Ltd (1.17M shares), Newtyn Management, LLC (1.15M shares), Samsara BioCapital, LLC (1.05M shares), VANGUARD GROUP INC (928K shares), ORBIMED ADVISORS LLC (771K shares), and Board of Trustees of The Leland Stanford Junior University (720K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.